2011
DOI: 10.1016/j.bone.2011.03.107
|View full text |Cite
|
Sign up to set email alerts
|

Life-threatening hypophosphatasia (HPP): Results of up to two years bone-targeted Enzyme Replacement Therapy (ERT) in infants and young children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2013
2013

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Although there is presently no approved medical treatment for the condition, enzyme replacement therapy may offer an effective treatment modality in the future 19 . Recently, bone‐targeted TNSALP has been used on a research basis in a number of severely affected infants as well as some older children with some promising provisional results 20,21 . Detailed trial results including dental outcomes have not yet been reported.…”
Section: Managementmentioning
confidence: 99%
“…Although there is presently no approved medical treatment for the condition, enzyme replacement therapy may offer an effective treatment modality in the future 19 . Recently, bone‐targeted TNSALP has been used on a research basis in a number of severely affected infants as well as some older children with some promising provisional results 20,21 . Detailed trial results including dental outcomes have not yet been reported.…”
Section: Managementmentioning
confidence: 99%